Pause in trading
Filed with ASX · · 1 page · English
Summary by 6ix AI
Botanix Pharmaceuticals Limited has announced a temporary pause in trading of its securities pending further announcement.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Botanix Pharmaceuticals Limited on 6ix
Earlier from Botanix Pharmaceuticals
- March 2025 Quarterly Activities Report and Appendix 4C
- Botanix $40 Million Capital Raising for Sofdra Rollout
- Botanix Conference Commercial Update
- S&P DJI Announces March 2025 Quarterly Rebalance
- December 2024 Quarterly Activities Report and Appendix 4C
Later from Botanix Pharmaceuticals
- Botanix Responds to US Pharmaceutical Pricing Announcement
- Response to ASX Price Query Letter
- Botanix Signs Debt Facility with Kreos Capital
- Botanix Provides Sofdra Launch Update
- June 2025 Quarterly Activities Report and Appendix 4C
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals